Veterinary Pharmacovigilance Market 2026–2030: Forecast, Innovation, and Competitive Trends

January 29, 2026January 29, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the kidulting toys market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Veterinary Pharmacovigilance Market by the end of 2030?

The veterinary pharmacovigilance market size has experienced significant expansion recently. This market is projected to expand from $0.91 billion in 2025 to reach $1.03 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.1%. Historically, this growth was driven by several factors, including the scarcity of formal pharmacovigilance frameworks within veterinary medicine, the increasing adoption of veterinary pharmaceuticals, a rise in companion animal healthcare expenditures, an escalation in reported adverse drug reactions among animals, and regulatory directives for monitoring drug safety.

The veterinary pharmacovigilance market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. This expansion during the forecast period stems from factors such as enhanced global veterinary drug regulations, an uptick in the creation of biologics and anti-infectives, a surge in the outsourcing of pharmacovigilance tasks, a heightened need for real-time safety monitoring solutions, and the increasing populations of livestock and companion animals. Key developments expected within the forecast timeframe encompass heightened regulatory examination of veterinary drug safety, wider acceptance of outsourced pharmacovigilance offerings, a greater emphasis on post-marketing surveillance for veterinary drugs, the broadening of adverse event reporting systems, and an improved understanding of drug safety among veterinary professionals.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21002&type=smp

What Drivers Are Shaping Future Opportunities In The Veterinary Pharmacovigilance Market?

The veterinary pharmacovigilance market is anticipated to expand due to the increasing need for animal health and medicinal products. These products encompass items like food, medications, and grooming essentials, all aimed at preserving the health and welfare of pets. This surge in demand stems from factors such as an increase in pet ownership, innovations in veterinary medicine, and the imperative for enhanced livestock productivity. Furthermore, heightened animal welfare consciousness and a greater occurrence of animal diseases also fuel this demand. Within pet care, veterinary pharmacovigilance plays a crucial role in guaranteeing the safety and effectiveness of pet medications through adverse effect monitoring and upholding regulatory standards. As an illustration, the Republic of Estonia’s Agency of Medicines (Ravimiamet), a national regulatory body based in Estonia, reported in March 2024 that the veterinary medicinal products sector in 2023 saw a 6.9% increase, growing from 17.4 million euros in 2022 to 18.6 million euros. Consequently, the rising demand for animal health and medicinal products is set to propel the expansion of the veterinary pharmacovigilance market.

Which Segment Groups Are Influencing The Veterinary Pharmacovigilance Market?

The veterinary pharmacovigilance market covered in this report is segmented –

1) By Type: In House, Outsourced

2) By Solution: Software, Services

3) By Drug Class: Biologics, Anti Infectives, Other Drug Classes

4) By Animal Type: Companion Animals, Livestock Animals, Other Animal Types

5) By End User: Veterinary Hospitals, Veterinary Companies, Academic And Research Institutes

Subsegments:

1) By In House: Internal Pharmacovigilance Departments, In-House Monitoring And Reporting Systems, Veterinary Adverse Event Management Software

2) By Outsourced: Third-Party Pharmacovigilance Services, Contract Research Organizations (CROs) For Pharmacovigilance, Pharmacovigilance Consulting And Support Services

Which Innovation Trends Are Advancing Developments Within The Veterinary Pharmacovigilance Market?

Within the veterinary pharmacovigilance market, leading companies are increasingly emphasizing the reinforcement of regulatory frameworks through advancements in data analytics, such as adverse event reporting (REAS) and the preparation of safety reports, to guarantee the safety and effectiveness of veterinary medications. Adverse event reporting (REAS) and the creation of safety reports involve the recording and analysis of detrimental responses to veterinary drugs, crucial for evaluating their safety and ensuring adherence to regulatory mandates. An illustration of this effort occurred in August 2024, when the Ministry of Agriculture and Rural Development, a governmental agency situated in Mexico, introduced a veterinary pharmacovigilance system. This Veterinary Pharmacovigilance System serves as a surveillance instrument created by SENASICA, designed to uphold the safety, quality, and effectiveness of veterinary drugs within Mexico. It gathers information concerning adverse reactions from various veterinary product managers, including pharmaceutical firms, distributors, veterinary hospitals, and veterinarians, with the goal of identifying, evaluating, and reducing the hazards linked to these drugs. The system incorporates the veterinary pharmacovigilance guide (REAS) to facilitate the documentation of adverse reactions and to oversee efficacy, residue thresholds, and environmental concerns.

Who Are The Top-Performing Companies In The Veterinary Pharmacovigilance Market In Recent Years?

Major companies operating in the veterinary pharmacovigilance market are Accenture PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Santé Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-pharmacovigilance-global-market-report

Which Region Currently Holds The Largest Share Of The Veterinary Pharmacovigilance Market?

North America was the largest region in the veterinary pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Pharmacovigilance Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21002&type=smp

Browse Through More Reports Similar to the Global Veterinary Pharmacovigilance Market 2026, By The Business Research Company

Veterinary Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Veterinary Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Veterinary Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795